Minoo Khalaj Asadi; Ziba Barghi Irani; Mahnaz Aliakbari
Abstract
Objective: Multiple sclerosis (MS) is a chronic and progressive nervous system disease. The present study aimed to compare the effectiveness of acceptance and commitment therapy (ACT) and cognitive behavioral therapy (CBT) on the psychosocial adjustment to illness and expanded disability of multiple ...
Read More
Objective: Multiple sclerosis (MS) is a chronic and progressive nervous system disease. The present study aimed to compare the effectiveness of acceptance and commitment therapy (ACT) and cognitive behavioral therapy (CBT) on the psychosocial adjustment to illness and expanded disability of multiple sclerosis patients.
Method: This research was a pretest-posttest controlled quasi-experimental study with a three-month and six-month follow-up. The research population was comprised of all MS patients in Tehran in 2021. Using the purposeful sampling method, 60 people were selected and randomly assigned to ACT and CBT experimental groups and the control group. Drogits' (1986) Psychosocial Adjustment to Illness Scale (PAIS) and expanded disability status scale (EDSS) were used to collect data. The ACT group received eight 120-minute sessions, the CBT group received eight one-hour sessions, and no intervention was provided for the control group. Covariance analysis and post hoc tests were used to analyze the data.
Results: The results demonstrated that ACT had a higher effect than CBT in enhancing psychosocial adjustment to illness (P=0.024) and reducing expanded disability (P=0.024), which has been constant in the follow-up stages.
Conclusion: In general, both ACT and CBT interventions significantly improved the psychosocial adjustment to illness and reduced the expanded disability of MS patients. However, it is suggested that professionals use ACT intervention for more effectiveness.
Mahsa Ghaffarzadeh; alinaghi aghdasi
Abstract
Objective: The aim of this study was to determine the effectiveness of group therapy of cognitive-behavioral approach on anxiety, stress, and despair of patients with Multiple sclerosis in Tehran.Method: This study was quasi-experimental with a pre-test-post-test design and a control group. Twenty patients ...
Read More
Objective: The aim of this study was to determine the effectiveness of group therapy of cognitive-behavioral approach on anxiety, stress, and despair of patients with Multiple sclerosis in Tehran.Method: This study was quasi-experimental with a pre-test-post-test design and a control group. Twenty patients who were referred to the available medical centers were selected as the study samples and randomly assigned into two experimental and control groups. In this study, Kalmogorov-Smirnov, Levene, and Covariance tests were used to analyze data through IBM SPSS software.Beck Anxiety Inventory Questionnaire, Cohen's Perceived Stress Questionnaire (PSQ), and Beck's Hopelessness Scale questionnaire were used to collect data.Results: The results of the present study showed that there is a significant difference between the experimental and control groups in terms of anxiety, stress, and despair with a 95% confidence level. Therefore, three main hypotheses were confirmed and the null hypothesis was rejected. It was found that cognitive-behavior group therapy was effective in reducing anxiety, stress, and despair in patients with MS.Conclusion: Cognitive-behavioral group therapy reduced stress, anxiety, and despair in patients with MS and improved their mental health. Therefore, this treatment method can be useful in clinics.
Afsaneh Dortaj; Mahnaz Aliakbari Dehkordi; Abdorreza Naser Moghadasi
Abstract
Objective: This study aimed to investigate the effectiveness of Cognitive-Behavioral Stress Management (CBSM) therapy on distress tolerance, pain perception, and interleukin-12 (IL-12) in patients with Multiple Sclerosis (MS).Method: The present study was a quasi-experimental design with pretest-posttest, ...
Read More
Objective: This study aimed to investigate the effectiveness of Cognitive-Behavioral Stress Management (CBSM) therapy on distress tolerance, pain perception, and interleukin-12 (IL-12) in patients with Multiple Sclerosis (MS).Method: The present study was a quasi-experimental design with pretest-posttest, follow-up, and control group. The statistical population included all female patients with relapsing-remitting MS who had been referred to Neuroscience and Rehabilitation Research Centers of Tehran Medical Sciences University. Among them, 20 patients were selected by convenience sampling and were randomly assigned to experimental (10 patients) and control groups (10 patients). The experimental group received the CBSM. Participants completed the research scales. To measure IL-12, the Enzyme-Linked Immunosorbent Assay (ELISA) was used. The data were analyzed using multivariate analysis of covariance (MANCOVA) and Bonferroni post-hoc test.Results: CBSM increased the distress tolerance and components of pain perception (perceived influence of important people and doing daily affairs) (p<0.001) and decreased pain severity and IL-12. Also, these changes remained stable during follow-up.Conclusions: CBSM is effective on distress tolerance, pain perception, and IL-12 in MS patients.
